Results 71 to 80 of about 12,798 (141)

Charles Bonnet Syndrome Precipitated by Brimonidine Tartrate Eye Drops

, 2002
To report Charles Bonnet syndrome precipitated by the use of brimonidine tartrate eye drops (Alphagan) in two elderly visually compromised ...
Robert L. Tomsak, MD, PhD
core  

Fixed combination brimonidine-timolol versus brimonidine for treatment of intraocular pressure elevation after neodymium: YAG laser posterior capsulotomy

, 2012
Purpose: To evaluate the efficacy of fixed combination brimonidine-timolol (FCBT) in comparison with brimonidine tartrate 0.2% and control for the treatment of intraocular pressure (IOP) spikes after neodymium:YAG (Nd:YAG) laser posterior capsulotomy ...
İşcan, Yalçın, Tas, Mehmet, Alakuş, Mehmet Fuat, Türkyılmaz, Kemal, Öner, Veysi   +4 more
core   +1 more source

Clinical efficacy of treatment for subclinical-stage axial diabetic optic neuropathy

Journal of Ophthalmology, 2018
Background: There is no standard of therapy for the treatment of diabetic optic neuropathy (DON). Purpose: To assess the clinical efficacy of thioctic acid, topical brimonidine tartrate and a combination of vitamins В1, В6, and В12 in the management ...
M.A. Karliychuk, P.A. Bezditko
doaj   +1 more source

Demographic and Clinical Factors associated with Brimonidine-Induced Ocular Allergy

, 2007
Purpose. Ocular allergy induced by brimonidine tartrate 0.2% is a common adverse event that is associated with poor compliance and therefore treatment failure.
Manni G., G. Manni
core   +1 more source

Identification of a non-purple tartrate-resistant acid phosphatase: An evolutionary link to Ser/Thr protein phosphatases? [PDF]

, 2008
Background: Tartrate-resistant acid phosphatases (TRAcPs), also known as purple acid phosphatases (PAPs), are a family of binuclear metallohydrolases that have been identified in plants, animals and fungi. The human enzyme is a major histochemical marker
David A Hume, Jodie Robinson, Gerhard Schenk, Hadler, K.ieran S., Burrows, Allan, Cassady A Ian, Hadler, K. S., Huber, Thomas, Guddat, L. W., Weber, J., Allan Burrows, Flanagan, J. U., Kelly Gregory, Robinson, J., Schenk Gerhard, Hume David A, Gregory Kelly, Robinson, Jodie, Huber Thomas, Guddat, Luke W., Burrows, A., Hadler, Kieran S., Burrows Allan, A Ian Cassady, Guddat, Luke W, Luke W Guddat, Hume, David A, Hume, D. A., Hume, David A., Kieran S Hadler, Flanagan, Jack U., Weber Jane, Robinson Jodie, Schenk, Gerhard, Kelly, Gregory, Hadler Kieran S, Jack U Flanagan, Jane Weber, Weber, Jane, Cassady, A. Ian, Cassady, A. I., Schenk, G., Guddat Luke W, Flanagan, Jack U, Flanagan Jack U, Huber, T., Hadler, Kieran S, Thomas Huber, Kelly, G., Cassady, Alan Ian   +49 more
core   +1 more source

Optic nerve head perfusion following treatment with latanoprost 0.005% versus brimonidine tartrate 0.2% in primary open angle glaucoma: an optical coherence tomography angiography study

Journal of the Egyptian Ophthalmological Society
Purpose To assess the effects of topical latanoprost 0.005% versus brimonidine tartrate 0.2% on perfusion of optic nerve head in patients with POAG using optical coherence tomography angiography.
Yasmine A. Deiaeldin, Mohammed A. Al-Naimy, Hani A. Albialy   +2 more
doaj   +1 more source

Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection [PDF]

Клиническая офтальмология, 2019
M. Kh. Khubetsova1, V.V. Kadyshev2, B.F. Ambalova3 1S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, Russian Federation 2Moscow Genetic Research Center, Moscow, Russian Federation 3Right-Shore Central Regional Clinical Hospital ...
M. Kh. Khubetsova, V.V. Kadyshev, B.F. Ambalova   +2 more
doaj  

Clinical efficacy of combination treatment for advanced-stage axial diabetic optic neuropathy

Journal of Ophthalmology, 2018
Background: There is no standard of therapy for diabetic optic neuropathy (DON) which takes into consideration the type and stage of the disease. Purpose: To assess the clinical efficacy of combined adjunct treatment with thioctic acid, a combination
M.A. Karliychuk
doaj   +1 more source

Brimonidine tartrate 0.1% eyedrops new and effective treatment of rosacea

, 2016
Objective To determine the efficacy of brimonidine tartrate eye drops for treatment of erythema associated with rosacea.   Methods Fifty patients with rosacea (41 females and 9 males, mean age 35 years) were   randomized to receive once daily single ...
Shazia Zubair, Ghulam Mujtaba
core   +1 more source

Pupillometry and diagnostic ultrasound of anterior segment effects of brimonidine tartrate 0.2 % and Apraclonidine 0.5%

, 2011
Apraclonidine 0.5% did not produce a significant effect on pupil diameter. Brimonidine tartrate 0.2% produced a moderate miotic effect. No effect was observed for apraclonidine 0.5%. A predominant agonistic effect on alpha–2 receptors of the iris dilator
Hardigan, Patrick C., Besada, E., Reed, K., Najman, P., Schtman, D.   +4 more
core   +1 more source